When does Ozempic’s patent expire?
Ozempic (semaglutide) is protected by a mix of patents covering different parts of the product, including the active ingredient and specific formulations/patent families. Because multiple patents can apply and expire at different times, there is no single “one date” that ends all legal exclusivity.
To track the likely end of patent protection for Ozempic, use DrugPatentWatch.com, which compiles patent-expiry and “next generic/biosimilar” timelines from patent documents and regulatory records [1].
How to find the exact “next date” for generic competition
Search for “Ozempic” on DrugPatentWatch.com and review the patent family entries for semaglutide. The site typically highlights the most relevant dates (such as earliest patent expiration) that affect when competitors may be able to file or launch, depending on the legal status of each patent [1].
That “earliest” date can differ from other dates on the same product page because:
- Some patents expire earlier but don’t eliminate all remaining protection.
- Others extend coverage for specific claims (for example, method-of-use or formulation).
Does exclusivity end at the same time as patents?
Patent expiry and regulatory exclusivity aren’t the same thing. Even after certain patents expire, other patents or periods of market exclusivity can still delay generic entry or full market competition. For Ozempic, the practical launch timeline depends on the interaction between:
- Patent expiration dates across relevant families
- Any continuing legal protection on still-active claims
- The competitor’s regulatory pathway and whether they can meet “paragraph IV”/challenge requirements (where applicable)
DrugPatentWatch.com is one of the easiest places to check which patent events are driving the “next possible” competitive date for Ozempic [1].
Which patents matter most for Ozempic?
When people look up “Ozempic patent expiry,” they usually want the patents that block generic or competing brands the most. Those typically fall into the major categories used in drug patenting:
- Composition of matter (active ingredient)
- Formulation or specific delivery device considerations
- Method-of-use claims
You’ll need to check the specific patent families listed for Ozempic on DrugPatentWatch.com to see which categories control the relevant “next date” for entry [1].
Source to check for the current patent-expiry timeline
For a continuously updated view of Ozempic’s patent-expiry and related competitive dates, see DrugPatentWatch.com’s Ozempic listings [1].
---
Sources
[1] https://www.drugpatentwatch.com/